[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2001053453A3 - Nouveaux acides nucleiques de moelle osseuse et polypeptides associes - Google Patents

Nouveaux acides nucleiques de moelle osseuse et polypeptides associes Download PDF

Info

Publication number
WO2001053453A3
WO2001053453A3 PCT/US2000/034960 US0034960W WO0153453A3 WO 2001053453 A3 WO2001053453 A3 WO 2001053453A3 US 0034960 W US0034960 W US 0034960W WO 0153453 A3 WO0153453 A3 WO 0153453A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
bone marrow
polypeptides
novel bone
marrow nucleic
Prior art date
Application number
PCT/US2000/034960
Other languages
English (en)
Other versions
WO2001053453A2 (fr
WO2001053453A8 (fr
Inventor
John E Ford
Bryan J Boyle
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Feiyan Ren
Jian-Rui Wang
Tom Werhman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Radoje T Drmanac
Original Assignee
Hyseq Inc
John E Ford
Bryan J Boyle
Y Tom Tang
Chenghua Liu
Vinod Asundi
Rui-Hong Chen
Yunqing Ma
Feiyan Ren
Jian-Rui Wang
Tom Werhman
Chongjun Xu
Aidong J Xue
Yonghong Yang
Jie Zhang
Qing A Zhao
Ping Zhou
Radoje T Drmanac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/620,312 external-priority patent/US6569662B1/en
Application filed by Hyseq Inc, John E Ford, Bryan J Boyle, Y Tom Tang, Chenghua Liu, Vinod Asundi, Rui-Hong Chen, Yunqing Ma, Feiyan Ren, Jian-Rui Wang, Tom Werhman, Chongjun Xu, Aidong J Xue, Yonghong Yang, Jie Zhang, Qing A Zhao, Ping Zhou, Radoje T Drmanac filed Critical Hyseq Inc
Priority to AU2001232657A priority Critical patent/AU2001232657A1/en
Publication of WO2001053453A2 publication Critical patent/WO2001053453A2/fr
Publication of WO2001053453A3 publication Critical patent/WO2001053453A3/fr
Publication of WO2001053453A8 publication Critical patent/WO2001053453A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La présente invention se rapporte à de nouveaux acides nucléiques exprimés dans la moelle épinière, à de nouvelles séquences polypeptidiques codées par ces acides nucléiques et à leurs utilisations.
PCT/US2000/034960 1999-12-23 2000-12-23 Nouveaux acides nucleiques de moelle osseuse et polypeptides associes WO2001053453A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001232657A AU2001232657A1 (en) 1999-12-23 2000-12-23 Novel bone marrow nucleic acids and polypeptides

Applications Claiming Priority (18)

Application Number Priority Date Filing Date Title
US47127599A 1999-12-23 1999-12-23
US09/471,275 1999-12-23
US48872500A 2000-01-21 2000-01-21
US09/488,725 2000-01-21
US55231700A 2000-04-25 2000-04-25
US09/552,317 2000-04-25
US59804200A 2000-06-20 2000-06-20
US09/598,042 2000-07-09
US09/620,312 US6569662B1 (en) 2000-01-21 2000-07-19 Nucleic acids and polypeptides
US09/620,312 2000-07-19
US65345000A 2000-08-31 2000-08-31
US09/653,450 2000-08-31
US66219100A 2000-09-14 2000-09-14
US09/662,191 2000-09-14
US69303600A 2000-10-19 2000-10-19
US09/693,036 2000-10-19
US25058300P 2000-11-30 2000-11-30
US60/250,583 2000-11-30

Publications (3)

Publication Number Publication Date
WO2001053453A2 WO2001053453A2 (fr) 2001-07-26
WO2001053453A3 true WO2001053453A3 (fr) 2002-06-20
WO2001053453A8 WO2001053453A8 (fr) 2002-08-29

Family

ID=27578737

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/034960 WO2001053453A2 (fr) 1999-12-23 2000-12-23 Nouveaux acides nucleiques de moelle osseuse et polypeptides associes

Country Status (1)

Country Link
WO (1) WO2001053453A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US7112420B2 (en) 2000-09-19 2006-09-26 Dana-Farber Cancer Institute Lymphoma associated molecules and uses therefor
GB2373502A (en) * 2000-11-08 2002-09-25 Smithkline Beecham Corp Suppressor of cytokine signalling 4 (SOCS4)
WO2002052005A1 (fr) * 2000-12-22 2002-07-04 Kazusa Dna Research Institute Foundation Genes et proteines codees par ceux-ci
US20030219739A1 (en) * 2001-01-30 2003-11-27 Glass David J. Novel nucleic acid and polypeptide molecules
EP1403368B1 (fr) * 2001-05-29 2010-09-01 Human Cell Systems, Inc. Transporteur de carnitine testiculaire et son gene
JP4219808B2 (ja) * 2001-08-23 2009-02-04 塩野義製薬株式会社 グアニンヌクレオチド交換因子様配列を有する新規遺伝子
EP1641922B1 (fr) 2003-07-07 2012-09-26 Universiteit Utrecht Holding B.V. Choline-phosphotransferases et ethanolamine-phosphotransferases nouvellement identifiees

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
LELIAS J. ET AL.: "cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins", PROC. NATL. ACAD. SCI, vol. 90, February 1993 (1993-02-01), USA, pages 1479 - 1483, XP002942326 *
MIRAGLIA S. ET AL.: "A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization, and Molecular Cloning", BLOOD, vol. 90, no. 12, 15 December 1997 (1997-12-15), pages 5013 - 5021, XP002942327 *
MOORE K.A. ET AL.: "Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs", PROC. NATL. ACAD. SCI., vol. 94, April 1997 (1997-04-01), USA, pages 4011 - 4016, XP002942328 *
PHILLIPS, R.L, ET AL.: "The Genetic Program of Hematopoietic Stem Cells", SCIENCE, vol. 288, 2 June 2000 (2000-06-02), pages 1635 - 1640, XP002942325 *

Also Published As

Publication number Publication date
WO2001053453A2 (fr) 2001-07-26
WO2001053453A8 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
WO2001053312A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001053455A3 (fr) Nouveaux acides nucleiques et polypeptides associes
WO2001075067A8 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057188A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001057190A3 (fr) Acides nucleiques et polypeptides
WO2002022660A3 (fr) Noveaux acides nucleiques et polypeptides
WO2001066689A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002031111A3 (fr) Acides nucleiques et polypeptides
WO2003054152A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003025148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002070539A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003023013A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002081731A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2001088088A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002059260A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004009834A3 (fr) Nouveaux acides nucleiques et polypeptides secretes
WO2004080148A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
EP2267010A3 (fr) Neurotoxines recombinantes activables
WO2002018424A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2004087874A3 (fr) Acides nucleiques et polypeptides
WO2001079449A3 (fr) Acides nucleiques et polypeptides nouveaux
WO2003080795A3 (fr) Nouveaux acides nucléiques et polypeptides sécrétés
WO2005049806A3 (fr) Nouveaux acides nucleiques et polypeptides
WO2002044340A3 (fr) Nouveaux acides nucleiques et polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP